DSpace Repository

Metabolism of Riboflavin By the Human Term Placenta

Show simple item record

dc.contributor.author Wheeler, Kim
dc.date.accessioned 2008-07-28T00:38:52Z
dc.date.accessioned 2022-10-31T20:46:13Z
dc.date.available 2008-07-28T00:38:52Z
dc.date.available 2022-10-31T20:46:13Z
dc.date.copyright 1995
dc.date.issued 1995
dc.identifier.uri https://ir.wgtn.ac.nz/handle/123456789/27006
dc.description.abstract Flavokinase (EC 2.7.1.26) converts riboflavin to FMN and FAD synthetase (EC 2.7.7.2) converts FMN to FAD. The presence of these enzymes was determined in the human term placenta. Placentas were obtained after vaginal or caesarean births. The placental tissue was scraped from the maternal side and the tissue was homogenised and centrifuged at 18,000 g. The 35-80% ammonium sulphate fraction, obtained from the supernatant, contained l00% of the flavokinase activity and possibly contained FAD synthetase activity. The presence of FMN and FAD as products of these assays was indicated by thin layer chromatography, high performance liquid chromatography and fast atom bombardment mass spectrometry. The conditions for the assay of placental flavokinase were examined in incubates with radiolabelled riboflavin as substrate and separation of product FMN by thin layer chromatography Placental flavokinase had an alkaline pH optimum but was routinely assayed at less than the optimum pH to minimise the effects of alkaline phosphatase. FMN production in the assay reached a maximum after l0 min incubation. ATP was essential for the activity of the enzyme. Placental flavokinase was partially purified using affinity chromatography. The undialysed 35-80% ammonium sulphate precipitate was mixed with blue Sepharose matrix and the protein was eluted from the column with water. The active fractions were combined and applied to an agarose C-8 ATP column. Application of a combination of these chromatography techniques gave an approximately 350-fold purification of the flavokinase from the placental homogenate. Gel permeation chromatography on a Biogel P-60 column indicated a MW of approximately 29,000 for the partially purified flavokinase. SDS polyacrylamide gel electrophoresis of the purified fractions also indicated the presence of protein bands at this MW range. In summary, the work presented in this thesis provides evidence that the human term placenta synthesises FMN and FAD from riboflavin and describes the purification and some of the properties of the flavokinase that catalyses the first step in the synthesis of the two coenzymes. en_NZ
dc.format pdf en_NZ
dc.language en_NZ
dc.language.iso en_NZ
dc.publisher Te Herenga Waka—Victoria University of Wellington en_NZ
dc.subject Placenta en_NZ
dc.subject Vitamin B2 en_NZ
dc.subject Metabolism en_NZ
dc.title Metabolism of Riboflavin By the Human Term Placenta en_NZ
dc.type Text en_NZ
vuwschema.type.vuw Awarded Doctoral Thesis en_NZ
thesis.degree.discipline Biochemistry en_NZ
thesis.degree.grantor Te Herenga Waka—Victoria University of Wellington en_NZ
thesis.degree.level Doctoral en_NZ
thesis.degree.name Doctor of Philosophy en_NZ


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account